Sol J. Barer, Director at Aevi Genomic Medicine, Inc. (GNMX), bought 5,102,040 shares at $0.96 ($4.9M) on 2018-08-15, disclosed to the SEC on 2018-08-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.96 | 2,551,020 | $2.4M | 50.0% |
| 2 | $0.96 | 2,551,020 | $2.4M | 50.0% |
| Total | $0.96 avg | 5,102,040 | $4.9M | 100% |
| Filing → |
| NEXI | BUY | 2022-06-02 | $312K | — | Filing → |
| NEXI | BUY | 2022-03-24 | $27K | — | Filing → |
| NEXI | BUY | 2022-03-23 | $72K | — | Filing → |